ARTFEED — Contemporary Art Intelligence

Medical Advance in Brazil Coincides with Diplomat's Health Crisis

artist · 2026-03-14

Stephanie Al-Qaq, the UK ambassador to Brazil, contracted dengue fever in December 2024 and developed a rare, severe complication leading to acute liver failure. She received an emergency liver transplant in January 2025 through Brazil's public health system, a procedure involving collaboration between Brazilian and British surgical teams. Her recovery coincided with Brazil's approval of Butantan-DV, the world's first single-dose dengue vaccine developed by Instituto Butantan, which shows high efficacy and could significantly impact global health as dengue spreads due to climate change.

Key facts

  • Stephanie Al-Qaq survived acute liver failure from dengue via liver transplant in Brazil
  • Brazil approved Butantan-DV, the first single-dose dengue vaccine, in late 2025
  • The vaccine shows 74.7% overall efficacy and 100% efficacy against hospitalizations
  • Dengue is expanding globally due to climate change, with over 14 million cases in 2024
  • Instituto Butantan plans to produce 60 million vaccine doses over two years

Entities

Institutions

  • Instituto Butantan
  • NHS
  • SUS
  • King's College Hospital

Locations

  • Brazil
  • Brasília
  • UK
  • São Paulo
  • Latin America

Sources